Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model.

Identifieur interne : 003689 ( PubMed/Corpus ); précédent : 003688; suivant : 003690

Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model.

Auteurs : Sivasakthivel Thirugnanam ; Pandurangan Pandiaraja ; Kalyanasundaram Ramaswamy ; Vadivel Murugan ; Munirathinam Gnanasekar ; Krithika Nandakumar ; Maryada Venkata Rami Reddy ; Perumal Kaliraj

Source :

RBID : pubmed:17442307

English descriptors

Abstract

Immunization of jirds with Bm-alt-2 elicited partial protection against challenge infection with the filarial parasite Brugia malayi. In this study, we initially compared the protective immune responses elicited following immunization with recombinant Bm-ALT-2 protein regimen and Bm-alt-2 DNA regimen. These studies showed that protein vaccination conferred approximately 75% protection compared to DNA vaccination that conferred only 57% protection. Analysis of the protective immune responses showed that the protein immunization promoted a Th2-biased response with an increase in IL-4, IL-5 and IgG1 responses, whereas, the DNA vaccine promoted a Th1-biased response with profound IFN-gamma and IgG2a responses. Since protein vaccination gave better results than DNA vaccination, we then wanted to evaluate whether a prime-boost vaccination that combined DNA prime and protein boost will significantly increase the protective responses induced by the protein vaccine. Our results suggest that prime-boost vaccination had no added advantage and was comparatively less effective (64% protection) than the Bm-ALT-2 protein alone vaccination. Prime boost vaccination generated mixed Th1/Th2 responses with a slightly diminished Th2 responses compared to protein vaccination. Thus, our results suggest that Bm-ALT-2 protein vaccination regimen may be slightly better than prime-boost vaccine regimen and the mechanism of protection appears to be largely mediated by a Th2-biased response.

DOI: 10.1016/j.exppara.2007.02.017
PubMed: 17442307

Links to Exploration step

pubmed:17442307

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model.</title>
<author>
<name sortKey="Thirugnanam, Sivasakthivel" sort="Thirugnanam, Sivasakthivel" uniqKey="Thirugnanam S" first="Sivasakthivel" last="Thirugnanam">Sivasakthivel Thirugnanam</name>
<affiliation>
<nlm:affiliation>Centre for Biotechnology, Anna University, Chennai 600 025, India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Pandiaraja, Pandurangan" sort="Pandiaraja, Pandurangan" uniqKey="Pandiaraja P" first="Pandurangan" last="Pandiaraja">Pandurangan Pandiaraja</name>
</author>
<author>
<name sortKey="Ramaswamy, Kalyanasundaram" sort="Ramaswamy, Kalyanasundaram" uniqKey="Ramaswamy K" first="Kalyanasundaram" last="Ramaswamy">Kalyanasundaram Ramaswamy</name>
</author>
<author>
<name sortKey="Murugan, Vadivel" sort="Murugan, Vadivel" uniqKey="Murugan V" first="Vadivel" last="Murugan">Vadivel Murugan</name>
</author>
<author>
<name sortKey="Gnanasekar, Munirathinam" sort="Gnanasekar, Munirathinam" uniqKey="Gnanasekar M" first="Munirathinam" last="Gnanasekar">Munirathinam Gnanasekar</name>
</author>
<author>
<name sortKey="Nandakumar, Krithika" sort="Nandakumar, Krithika" uniqKey="Nandakumar K" first="Krithika" last="Nandakumar">Krithika Nandakumar</name>
</author>
<author>
<name sortKey="Reddy, Maryada Venkata Rami" sort="Reddy, Maryada Venkata Rami" uniqKey="Reddy M" first="Maryada Venkata Rami" last="Reddy">Maryada Venkata Rami Reddy</name>
</author>
<author>
<name sortKey="Kaliraj, Perumal" sort="Kaliraj, Perumal" uniqKey="Kaliraj P" first="Perumal" last="Kaliraj">Perumal Kaliraj</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17442307</idno>
<idno type="pmid">17442307</idno>
<idno type="doi">10.1016/j.exppara.2007.02.017</idno>
<idno type="wicri:Area/PubMed/Corpus">003689</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003689</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model.</title>
<author>
<name sortKey="Thirugnanam, Sivasakthivel" sort="Thirugnanam, Sivasakthivel" uniqKey="Thirugnanam S" first="Sivasakthivel" last="Thirugnanam">Sivasakthivel Thirugnanam</name>
<affiliation>
<nlm:affiliation>Centre for Biotechnology, Anna University, Chennai 600 025, India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Pandiaraja, Pandurangan" sort="Pandiaraja, Pandurangan" uniqKey="Pandiaraja P" first="Pandurangan" last="Pandiaraja">Pandurangan Pandiaraja</name>
</author>
<author>
<name sortKey="Ramaswamy, Kalyanasundaram" sort="Ramaswamy, Kalyanasundaram" uniqKey="Ramaswamy K" first="Kalyanasundaram" last="Ramaswamy">Kalyanasundaram Ramaswamy</name>
</author>
<author>
<name sortKey="Murugan, Vadivel" sort="Murugan, Vadivel" uniqKey="Murugan V" first="Vadivel" last="Murugan">Vadivel Murugan</name>
</author>
<author>
<name sortKey="Gnanasekar, Munirathinam" sort="Gnanasekar, Munirathinam" uniqKey="Gnanasekar M" first="Munirathinam" last="Gnanasekar">Munirathinam Gnanasekar</name>
</author>
<author>
<name sortKey="Nandakumar, Krithika" sort="Nandakumar, Krithika" uniqKey="Nandakumar K" first="Krithika" last="Nandakumar">Krithika Nandakumar</name>
</author>
<author>
<name sortKey="Reddy, Maryada Venkata Rami" sort="Reddy, Maryada Venkata Rami" uniqKey="Reddy M" first="Maryada Venkata Rami" last="Reddy">Maryada Venkata Rami Reddy</name>
</author>
<author>
<name sortKey="Kaliraj, Perumal" sort="Kaliraj, Perumal" uniqKey="Kaliraj P" first="Perumal" last="Kaliraj">Perumal Kaliraj</name>
</author>
</analytic>
<series>
<title level="j">Experimental parasitology</title>
<idno type="ISSN">0014-4894</idno>
<imprint>
<date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Antibodies, Helminth (biosynthesis)</term>
<term>Antibodies, Helminth (blood)</term>
<term>Antigens, Helminth (genetics)</term>
<term>Antigens, Helminth (immunology)</term>
<term>Brugia malayi (immunology)</term>
<term>Cytokines (biosynthesis)</term>
<term>Cytokines (genetics)</term>
<term>DNA, Helminth (immunology)</term>
<term>Diffusion Chambers, Culture</term>
<term>Disease Models, Animal</term>
<term>Elephantiasis, Filarial (prevention & control)</term>
<term>Gerbillinae</term>
<term>Helminth Proteins (genetics)</term>
<term>Helminth Proteins (immunology)</term>
<term>Immunity, Cellular</term>
<term>Immunization (methods)</term>
<term>Lymphocyte Activation</term>
<term>Male</term>
<term>Recombinant Proteins (genetics)</term>
<term>Recombinant Proteins (immunology)</term>
<term>Th2 Cells (immunology)</term>
<term>Vaccines (immunology)</term>
<term>Vaccines, DNA (immunology)</term>
<term>Vaccines, Synthetic (immunology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>Antibodies, Helminth</term>
<term>Cytokines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Antibodies, Helminth</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Antigens, Helminth</term>
<term>Cytokines</term>
<term>Helminth Proteins</term>
<term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Antigens, Helminth</term>
<term>DNA, Helminth</term>
<term>Helminth Proteins</term>
<term>Recombinant Proteins</term>
<term>Vaccines</term>
<term>Vaccines, DNA</term>
<term>Vaccines, Synthetic</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Brugia malayi</term>
<term>Th2 Cells</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Immunization</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Diffusion Chambers, Culture</term>
<term>Disease Models, Animal</term>
<term>Gerbillinae</term>
<term>Immunity, Cellular</term>
<term>Lymphocyte Activation</term>
<term>Male</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Immunization of jirds with Bm-alt-2 elicited partial protection against challenge infection with the filarial parasite Brugia malayi. In this study, we initially compared the protective immune responses elicited following immunization with recombinant Bm-ALT-2 protein regimen and Bm-alt-2 DNA regimen. These studies showed that protein vaccination conferred approximately 75% protection compared to DNA vaccination that conferred only 57% protection. Analysis of the protective immune responses showed that the protein immunization promoted a Th2-biased response with an increase in IL-4, IL-5 and IgG1 responses, whereas, the DNA vaccine promoted a Th1-biased response with profound IFN-gamma and IgG2a responses. Since protein vaccination gave better results than DNA vaccination, we then wanted to evaluate whether a prime-boost vaccination that combined DNA prime and protein boost will significantly increase the protective responses induced by the protein vaccine. Our results suggest that prime-boost vaccination had no added advantage and was comparatively less effective (64% protection) than the Bm-ALT-2 protein alone vaccination. Prime boost vaccination generated mixed Th1/Th2 responses with a slightly diminished Th2 responses compared to protein vaccination. Thus, our results suggest that Bm-ALT-2 protein vaccination regimen may be slightly better than prime-boost vaccine regimen and the mechanism of protection appears to be largely mediated by a Th2-biased response.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">17442307</PMID>
<DateCreated>
<Year>2007</Year>
<Month>06</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted>
<Year>2007</Year>
<Month>08</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised>
<Year>2016</Year>
<Month>11</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0014-4894</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>116</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2007</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Experimental parasitology</Title>
<ISOAbbreviation>Exp. Parasitol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model.</ArticleTitle>
<Pagination>
<MedlinePgn>483-91</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Immunization of jirds with Bm-alt-2 elicited partial protection against challenge infection with the filarial parasite Brugia malayi. In this study, we initially compared the protective immune responses elicited following immunization with recombinant Bm-ALT-2 protein regimen and Bm-alt-2 DNA regimen. These studies showed that protein vaccination conferred approximately 75% protection compared to DNA vaccination that conferred only 57% protection. Analysis of the protective immune responses showed that the protein immunization promoted a Th2-biased response with an increase in IL-4, IL-5 and IgG1 responses, whereas, the DNA vaccine promoted a Th1-biased response with profound IFN-gamma and IgG2a responses. Since protein vaccination gave better results than DNA vaccination, we then wanted to evaluate whether a prime-boost vaccination that combined DNA prime and protein boost will significantly increase the protective responses induced by the protein vaccine. Our results suggest that prime-boost vaccination had no added advantage and was comparatively less effective (64% protection) than the Bm-ALT-2 protein alone vaccination. Prime boost vaccination generated mixed Th1/Th2 responses with a slightly diminished Th2 responses compared to protein vaccination. Thus, our results suggest that Bm-ALT-2 protein vaccination regimen may be slightly better than prime-boost vaccine regimen and the mechanism of protection appears to be largely mediated by a Th2-biased response.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Thirugnanam</LastName>
<ForeName>Sivasakthivel</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Centre for Biotechnology, Anna University, Chennai 600 025, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pandiaraja</LastName>
<ForeName>Pandurangan</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ramaswamy</LastName>
<ForeName>Kalyanasundaram</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Murugan</LastName>
<ForeName>Vadivel</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gnanasekar</LastName>
<ForeName>Munirathinam</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nandakumar</LastName>
<ForeName>Krithika</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reddy</LastName>
<ForeName>Maryada Venkata Rami</ForeName>
<Initials>MV</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kaliraj</LastName>
<ForeName>Perumal</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AI064745</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AI064745-02</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R56 AI064745</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R56 AI064745-01A1</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2007</Year>
<Month>03</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Exp Parasitol</MedlineTA>
<NlmUniqueID>0370713</NlmUniqueID>
<ISSNLinking>0014-4894</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C521555">ALT-2 protein, Brugia malayi</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000909">Antibodies, Helminth</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018509">DNA, Helminth</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015801">Helminth Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014612">Vaccines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019444">Vaccines, DNA</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014614">Vaccines, Synthetic</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2001 Jan 15;183(2):303-312</RefSource>
<PMID Version="1">11110648</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2000 Jul;68(7):4174-9</RefSource>
<PMID Version="1">10858234</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Biochem Parasitol. 2001 Nov;118(1):89-96</RefSource>
<PMID Version="1">11704277</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Microbiol Immunol. 2003 Feb;192(1):23-31</RefSource>
<PMID Version="1">12592560</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Trop Med Parasitol. 2002 Dec;96 Suppl 2:S97-104</RefSource>
<PMID Version="1">12625923</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vet Microbiol. 2003 Jun 10;93(4):349-59</RefSource>
<PMID Version="1">12713896</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Parasitol. 2003 Nov;19(11):516-22</RefSource>
<PMID Version="1">14580963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2004 Aug;72(8):4707-15</RefSource>
<PMID Version="1">15271932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11088-93</RefSource>
<PMID Version="1">15258286</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vaccine. 2004 Sep 9;22(27-28):3622-7</RefSource>
<PMID Version="1">15315841</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Jpn J Exp Med. 1979 Apr;49(2):117-21</RefSource>
<PMID Version="1">384057</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Trop Med Hyg. 1989 Jun;40(6):598-604</RefSource>
<PMID Version="1">2662785</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 1992 Jun 15;148(12):3733-9</RefSource>
<PMID Version="1">1351086</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 1993 Mar 1;150(5):1881-5</RefSource>
<PMID Version="1">8436822</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Trop Med Hyg. 1993 Dec;49(6):783-8</RefSource>
<PMID Version="1">8279644</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Eur J Immunol. 1995 May;25(5):1477-80</RefSource>
<PMID Version="1">7774653</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Immunol. 1996 Nov 1;173(2):192-7</RefSource>
<PMID Version="1">8912876</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Pharm Sci. 1996 Dec;85(12):1294-300</RefSource>
<PMID Version="1">8961142</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vaccine. 1997 Jun;15(8):842-5</RefSource>
<PMID Version="1">9234529</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9378-83</RefSource>
<PMID Version="1">9256490</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunol Cell Biol. 1997 Aug;75(4):370-5</RefSource>
<PMID Version="1">9315480</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hum Gene Ther. 1998 Sep 1;9(13):1899-907</RefSource>
<PMID Version="1">9741428</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bull World Health Organ. 1999;77(2):138-43</RefSource>
<PMID Version="1">10083712</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Exp Parasitol. 1999 Apr;91(4):334-40</RefSource>
<PMID Version="1">10092477</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vaccine. 1999 Aug 20;18(1-2):76-81</RefSource>
<PMID Version="1">10501237</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2004 Dec;72(12):6945-50</RefSource>
<PMID Version="1">15557616</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Microbiol Immunol. 2004;48(12):945-55</RefSource>
<PMID Version="1">15611611</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vaccine. 2005 May 16;23(26):3446-52</RefSource>
<PMID Version="1">15837368</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Trop Med Hyg. 2005 Oct;73(4):753-8</RefSource>
<PMID Version="1">16222021</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2006 Mar 25;367(9515):992-9</RefSource>
<PMID Version="1">16564361</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vaccine. 2006 Jul 26;24(31-32):5787-99</RefSource>
<PMID Version="1">16759763</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vaccine. 1999 Nov 12;18(7-8):647-55</RefSource>
<PMID Version="1">10547424</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 1999 Dec 15;163(12):6448-54</RefSource>
<PMID Version="1">10586035</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vaccine. 2000 Jan 31;18(14):1367-73</RefSource>
<PMID Version="1">10618534</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2000 May;68(5):2513-7</RefSource>
<PMID Version="1">10768938</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2000 May;68(5):3034-5</RefSource>
<PMID Version="1">10769010</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parasite Immunol. 2000 May;22(5):249-57</RefSource>
<PMID Version="1">10792764</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Infect Immun. 2000 Jun;68(6):3651-6</RefSource>
<PMID Version="1">10816524</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gut. 2001 Jun;48(6):765-73</RefSource>
<PMID Version="1">11358893</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000909" MajorTopicYN="N">Antibodies, Helminth</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017178" MajorTopicYN="N">Brugia malayi</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018509" MajorTopicYN="N">DNA, Helminth</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015194" MajorTopicYN="N">Diffusion Chambers, Culture</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005849" MajorTopicYN="N">Gerbillinae</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015801" MajorTopicYN="N">Helminth Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007111" MajorTopicYN="N">Immunity, Cellular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018418" MajorTopicYN="N">Th2 Cells</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014612" MajorTopicYN="N">Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019444" MajorTopicYN="N">Vaccines, DNA</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014614" MajorTopicYN="N">Vaccines, Synthetic</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS126827</OtherID>
<OtherID Source="NLM">PMC2763209</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2006</Year>
<Month>09</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2007</Year>
<Month>02</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2007</Year>
<Month>02</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2007</Year>
<Month>4</Month>
<Day>20</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2007</Year>
<Month>8</Month>
<Day>2</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2007</Year>
<Month>4</Month>
<Day>20</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">17442307</ArticleId>
<ArticleId IdType="pii">S0014-4894(07)00061-6</ArticleId>
<ArticleId IdType="doi">10.1016/j.exppara.2007.02.017</ArticleId>
<ArticleId IdType="pmc">PMC2763209</ArticleId>
<ArticleId IdType="mid">NIHMS126827</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003689 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003689 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:17442307
   |texte=   Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:17442307" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024